Target intelligence / Profile preview

Sodium-dependent phosphate transporter 2 (SLC20A2)

Target
SLC20A2
Molecular classification
Transporter, Solute carrier, Sodium-dependent phosphate symporter, Type III sodium-phosphate co-transporter
01

Overview

Sodium-dependent phosphate transporter 2 (SLC20A2, PiT-2) is a transmembrane transporter belonging to the solute carrier family, critical for the sodium-dependent uptake of inorganic phosphate. It forms homodimers, operates primarily in the brain and bone, and is essential for normal cellular function, including energy metabolism and nucleic acid synthesis. SLC20A2 also acts as a cell surface receptor for certain retroviruses. Pathogenic mutations cause phosphate metabolism dysfunction and abnormal calcium-phosphate deposition in the brain, notably leading to diseases like primary familial brain calcification (Fahr's syndrome), and are implicated in bone quality and strength. Its dual role in transport and viral entry underscores a diverse functional and clinical significance

Other names
PiT-2SLC20A2Sodium-dependent phosphate transporter 2Gibbon ape leukemia virus receptor 2GLVR2MLVARMurine leukemia virus amphotropic receptor
02

Mechanism of action

For potential drugs: inhibition or modulation of phosphate transport to correct or mitigate abnormal mineralization and calcification. For retroviral entry, blockade of viral-receptor interaction.

03

Biological functions

Phosphate transport (uptake into cells using sodium as a cofactor)Maintenance of phosphate homeostasisCellular metabolismSignal transductionNucleic acid and lipid synthesisTissue mineralizationReceptor for certain retrovirusesNeuronal plasticity and memory regulation
04

Disease associations

Primary familial brain calcification (including familial idiopathic basal ganglia calcification / Fahr's syndrome)Disorders of phosphate metabolismOsteoporosis (altered bone mineralization and bone quality)Neurodegenerative diseases (potentially)
05

Safety considerations

Targeting or loss-of-function of SLC20A2 can cause impaired phosphate homeostasis, abnormal tissue mineralization (including brain and bone), neurological symptoms, cognitive dysfunction, and increased inflammation
06

Interacting drugs

None are currently approved or well-documented to directly target SLC20A2; research is preclinical and mostly genetic. However, phosphate homeostasis and calcification processes may be indirectly affected by drugs that alter phosphate, calcium, or vitamin D metabolism.
07

Biomarkers

Mutations in SLC20A2 are a biomarker for familial brain calcification and related neurological disorders

Beyond the preview

Go deeper on Sodium-dependent phosphate transporter 2 (SLC20A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent phosphate transporter 2 (SLC20A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call